CALAMUS

OTHER NAME(S):

Acore Odorant, Acore Olorant, Acore Roseau, Acorus americanus, Acorus calamus, Acorus gramineus, Acorus Roseau, Bach, Belle-Angélique, Cálamo, Cinnamon Sedge, Flagroot, Gladdon, Grass-Leaf Sweetflag, Grass Myrtle, Kalmus, Myrtle Flag, Myrtle Sedge, Sadgrantha, Sweet Calamus, Sweet Cane, Sweet Cinnamon, Sweet Flag, Sweet Grass, Sweet Myrtle, Sweet Root, Sweet Rush, Sweet Sedge, Ugragandha, Vach, Vacha, Vachha, Vaj, Vayambur.<br/><br/>

Overview

Overview Information

Calamus is a plant. The root (rhizome) is used to make medicine.

Despite safety concerns, calamus is used for gastrointestinal (GI) problems including ulcers, inflammation of the stomach lining (gastritis), intestinal gas (flatulence), upset stomach and loss of appetite (anorexia). Calamus is also used as a calming medicine (sedative), to induce sweating, and to treat rheumatoid arthritis and stroke.

Some people chew calamus to remove the smell of tobacco, as a stimulant, to increase their sense of well-being, and as a hallucinogen.

Some people apply calamus directly to the skin to treat certain skin diseases.

In foods, calamus is used as a spice.

How does it work?

It is thought that chemicals in calamus cause muscle relaxation and sedation.

Uses

Uses & Effectiveness?

Insufficient Evidence for

More evidence is needed to rate the effectiveness of calamus for these uses.

Side Effects

Side Effects & Safety

Calamus is LIKELY UNSAFE when taken by mouth. It can cause kidney damage, shaking, and seizures.

The FDA prohibits calamus use in food products because three of the four species of calamus found in the world contain a cancer–causing chemical called beta-isoasarone. However, the beta-isoasarone content can vary widely among species from 0% to 96%. Some products may be safer than others.

Special Precautions & Warnings:

Pregnancy and breast-feeding: Calamus is LIKELY UNSAFE when taken by mouth during pregnancy or breast-feeding. Avoid use.

Heart conditions: Calamus might lower blood pressure and heart rate. In theory, large amounts of calamus might worsen heart problems in some people with heart conditions.

Low blood pressure: Calamus might lower blood pressure. In theory, taking calamus might make blood pressure become too low in people with low blood pressure.

Surgery: Calamus can affect the central nervous system. It might cause too much sleepiness if combined with medications used during and after surgery. If you are using calamus despite safety concerns, stop using it at least 2 weeks before a scheduled surgery.

Interactions

Interactions?

Moderate Interaction

Be cautious with this combination

!
  • Medications for depression (MAOIs) interacts with CALAMUS

    Calamus contains a chemical that affects the body. This chemical might increase the side effects of some medications used for depression.<nb>Some of these medications used for depression include phenelzine (Nardil), tranylcypromine (Parnate), and others.

  • Sedative medications (CNS depressants) interacts with CALAMUS

    Calamus might cause sleepiness and drowsiness. Medications that cause sleepiness are called sedatives. Taking calamus along with sedative medications might cause too much sleepiness.<nb>Some sedative medications include clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), and others.

Minor Interaction

Be watchful with this combination

!
  • Antacids interacts with CALAMUS

    Antacids are used to decrease stomach acid. Calamus may increase stomach acid. By increasing stomach acid, calamus might decrease the effectiveness of antacids.<nb>Some antacids include calcium carbonate (Tums, others), dihydroxyaluminum sodium carbonate (Rolaids, others), magaldrate (Riopan), magnesium sulfate (Bilagog), aluminum hydroxide (Amphojel), and others.

  • Medications that decrease stomach acid (H2-Blockers) interacts with CALAMUS

    Calamus might increase stomach acid. By increasing stomach acid, calamus might decrease the effectiveness of some medications that decrease stomach acid, called H2-Blockers.<nb>Some medications that decrease stomach acid include cimetidine (Tagamet), ranitidine (Zantac), nizatidine (Axid), and famotidine (Pepcid).

  • Medications that decrease stomach acid (Proton pump inhibitors) interacts with CALAMUS

    Calamus might increase stomach acid. By increasing stomach acid, calamus might decrease the effectiveness of medications that are used to decrease stomach acid, called proton pump inhibitors.<nb>Some medications that decrease stomach acid include omeprazole (Prilosec), lansoprazole (Prevacid), rabeprazole (Aciphex), pantoprazole (Protonix), and esomeprazole (Nexium).

Dosing

Dosing

The appropriate dose of calamus depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for calamus. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

  • Acuna, U. M., Atha, D. E., Ma, J., Nee, M. H., and Kennelly, E. J. Antioxidant capacities of ten edible North American plants. Phytother Res 2002;16(1):63-65. View abstract.
  • AGARWAL, S. L., ARORA, R. B., Dandiya, P. C., and SINGH, K. P. A note on the preliminary studies of certain pharmacological actions of Acorus calamus L. J Am.Pharm.Assoc.Am.Pharm.Assoc.(Baltim.) 1956;45(9):655-656. View abstract.
  • Ahmad, I. and Aqil, F. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESbetaL-producing multidrug-resistant enteric bacteria. Microbiol.Res 7-26-2006; View abstract.
  • Albertazzi, F. J., Kudla, J., and Bock, R. The cox2 locus of the primitive angiosperm plant Acorus calamus: molecular structure, transcript processing and RNA editing. Mol.Gen.Genet. 1998;259(6):591-600. View abstract.
  • Aqil, F., Ahmad, I., and Owais, M. Evaluation of anti-methicillin-resistant Staphylococcus aureus (MRSA) activity and synergy of some bioactive plant extracts. Biotechnol.J 2006;1(10):1093-1102. View abstract.
  • Bains, J. S., Dhuna, V., Singh, J., Kamboj, S. S., Nijjar, K. K., and Agrewala, J. N. Novel lectins from rhizomes of two Acorus species with mitogenic activity and inhibitory potential towards murine cancer cell lines. Int Immunopharmacol. 2005;5(9):1470-1478. View abstract.
  • Barsteigiene, Z., Janulis, V., Skyrius, V., and Savickiene, N. [Herbal medicinal preparations in the Lithuanian market]. Medicina (Kaunas.) 2003;39 Suppl 2:1-3. View abstract.
  • Beaulieu, J. E. Herbal therapy interactions with immunosuppressive agents. US Pharmacist (USA) 2001;26:HS-13-HS-14, HS-17-HS-18, HS-21-HS-22.
  • Bertea, C. M., Azzolin, C. M., Bossi, S., Doglia, G., and Maffei, M. E. Identification of an EcoRI restriction site for a rapid and precise determination of beta-asarone-free Acorus calamus cytotypes. Phytochemistry 2005;66(5):507-514. View abstract.
  • BOROWSKI, J. [Effect of decoction of rhizoma of Acorus calomus on secretory function.]. Pol.Tyg.Lek.(Wars.) 11-21-1955;10(47):1533-1535. View abstract.
  • BOSE, B. C., VIJAYVARGIYA, R., SAIFI, A. Q., and SHARMA, S. K. Some aspects of chemical and pharmacological studies of Acorus calamus Linn. J Am.Pharm.Assoc.Am.Pharm.Assoc. 1960;49:32-34. View abstract.
  • Bucher, M. and Kuhlemeier, C. Long-term anoxia tolerance. Multi-level regulation of gene expression in the amphibious plant Acorus calamus L. Plant Physiol 1993;103(2):441-448. View abstract.
  • Buzgo, M. and Endress, P. K. Floral structure and development of Acoraceae and its systematic relationships with basal angiosperms. INTERNATIONAL JOURNAL OF PLANT SCIENCES 2000;161(1):23-41. View abstract.
  • Chavez, M. L. Toxicology and Clinical Pharmacology of Herbal Products (Book Review). Pharmaceutical Biology 2001;39(2):158.
  • Chen, L. and Liao, W. P. [Changes of amino acid content in hippocampus of epileptic rats treated with volatile oil of Acorus tatarinowii]. Zhongguo Zhong.Yao Za Zhi. 2004;29(7):670-673. View abstract.
  • Chit, K., Myint, W., Thein, K., Maw, W. W., Myint M.M., Than, A., and Khin, M. Cyclic AMP phosphodiesterase inhibitory activity and chemical screening of four medicinal plants. Pharmaceutical Biology 2001;39(3):181-183.
  • Cho, J., Kim, Y. H., Kong, J. Y., Yang, C. H., and Park, C. G. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci. 6-21-2002;71(5):591-599. View abstract.
  • Cho, J., Kong, J. Y., Jeong, D. Y., Lee, K. D., Lee, D. U., and Kang, B. S. NMDA recepter-mediated neuroprotection by essential oils from the rhizomes of Acorus gramineus. Life Sci. 2-16-2001;68(13):1567-1573. View abstract.
  • Choi, H. S. Aroma evaluation of an aquatic herb, Changpo (Acorus calamus Var. angustatus Bess), by AEDA and SPME. J Agric.Food Chem 12-29-2004;52(26):8099-8104. View abstract.
  • CHOPRA, I. C., JAMWAL, K. S., and KHAJURIA, B. N. Pharmacological action of some common essential oil-bearing plants used in indigenous medicine. I. Pharmacological action of Acorus calamus, Curcuma zedoaria, Xanthoxylum alatum and Angelica archangelica. Indian J Med Res 1954;42(3):381-384. View abstract.
  • CHOPRA, M. M., VASHIST, V. N., and HANDA, K. L. CHROMATOGRAPHIC ESTIMATION OF ASARONES IN INDIAN ACORUS CALAMUS LINN. OIL (TETRAPLOID VARIETY). J Chromatogr. 1965;17:195-196. View abstract.
  • Chowdhury, A. K., Ara, T., Hashim, M. F., and Ahmed, M. New phenyl propane derivative from Acorus calamus. Die Pharmazie (Germany) 1993;48:786-787.
  • Clutton, D. W. History of gin. Flavour Ind. 1972;3:454-456.
  • Dandiya, P. C. and CULLUMBINE, H. Studies on Acorus calamus (III); some pharmacological actions of the volatile oil. J Pharmacol.Exp.Ther. 1959;125(4):353-359. View abstract.
  • Dandiya, P. C. and SHARMA, J. D. Studies on Acorus calamus. V. Pharmacological actions of asarone and beta-asarone on central nervous system. Indian J Med Res 1962;50:46-60. View abstract.
  • Dandiya, P. C., BAXTER, R. M., WALKER, G. C., and CULLUMBINE, H. Studies on Acorus calamus. II. Investigation of volatile oil. J Pharm.Pharmacol. 1959;11(3):163-168. View abstract.
  • Dandiya, P. C., CULLUMBINE, H., and SELLERS, E. A. Studies on Acorus calamus. IV. Investigations on mechanism of action in mice. J Pharmacol.Exp.Ther. 1959;126:334-337. View abstract.
  • DAS, P. K., MALHOTRA, C. L., and Dhalla, N. S. Spasmolytic activity of asarone and essential oil of Acorus calamus, Linn. Arch Int Pharmacodyn.Ther. 1-1-1962;135:167-177. View abstract.
  • Deng, C., Li, N., and Zhang, X. Rapid determination of essential oil in Acorus tatarinowii Schott. by pressurized hot water extraction followed by solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr.A 12-3-2004;1059(1-2):149-155. View abstract.
  • Dennehy, C. E., Tsourounis, C., and Miller, A. E. Evaluation of herbal dietary supplements marketed on the internet for recreational use. Ann.Pharmacother 2005;39(10):1634-1639. View abstract.
  • Dhalla, N. S. and Bhattacharya, I. C. Further studies on neuropharmacological actions of acorus oil. Arch Int Pharmacodyn.Ther. 1968;172(2):356-365. View abstract.
  • Duvall, M. R., Learn, G. H., Jr., Eguiarte, L. E., and Clegg, M. T. Phylogenetic analysis of rbcL sequences identifies Acorus calamus as the primal extant monocotyledon. Proc.Natl.Acad.Sci.U.S.A 5-15-1993;90(10):4641-4644. View abstract.
  • El'iashevich, O. G., Koreshchuk, K. E., Bezugla, N. I., and Drozd, G. A. [Spectrophotometric method for determining flavonoids in the aerial mass of the sweet flag]. Farm.Zh. 1974;29(2):92-93. View abstract.
  • Gacche, R. N. and Dhole, N. A. Antioxidant and Possible Anti-Inflammatory Potential of Selected Medicinal Plants Prescribed in the Indian Traditional System of Medicine. Pharmaceutical Biology 2006;44(5):389-395.
  • Ghosh, M. Antifungal properties of haem peroxidase from Acorus calamus. Ann.Bot.(Lond) 2006;98(6):1145-1153. View abstract.
  • Gilani, A. U., Shah, A. J., Ahmad, M., and Shaheen, F. Antispasmodic effect of Acorus calamus Linn. is mediated through calcium channel blockade. Phytother Res 2006;20(12):1080-1084. View abstract.
  • Goggelmann, W. and Schimmer, O. Mutagenicity testing of beta-asarone and commercial calamus drugs with Salmonella typhimurium. Mutat.Res 1983;121(3-4):191-194. View abstract.
  • Goremykin, V. V., Holland, B., Hirsch-Ernst, K. I., and Hellwig, F. H. Analysis of Acorus calamus chloroplast genome and its phylogenetic implications. Mol.Biol Evol. 2005;22(9):1813-1822. View abstract.
  • Hanson, K. M., Gayton-Ely, M., Holland, L. A., Zehr, P. S., and Soderberg, B. C. Rapid assessment of beta-asarone content of Acorus calamus by micellar electrokinetic capillary chromatography. Electrophoresis 2005;26(4-5):943-946. View abstract.
  • He, C. Q. and Wang, C. K. Allelopathic effect of Acorus tatarinowii upon algae. J Environ.Sci.(China) 2001;13(4):481-484. View abstract.
  • Hidayatulfathi, O., Sallehuddin, S., and Ibrahim, J. Adulticidal activity of some Malaysian plant extracts against Aedes aegypti Linnaeus. Trop.Biomed 2004;21(2):61-67. View abstract.
  • Hu, B. Y. and Ji, Y. Y. [Research on the anticarcinogenic activation of Acorus calcamus. Anticarcinogenic activation of alpha-asarone on human carcinoma cells]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1986;6(8):480-3, 454. View abstract.
  • Hu, J. and Feng, X. Phenylpropanes from Acorus tatarinowii. Planta Med 2000;66(7):662-664. View abstract.
  • Ka, M. H., Choi, E. H., Chun, H. S., and Lee, K. G. Antioxidative activity of volatile extracts isolated from Angelica tenuissimae roots, peppermint leaves, pine needles, and sweet flag leaves. J Agric.Food Chem. 5-18-2005;53(10):4124-4129. View abstract.
  • Keller, K., Odenthal, K. P., and Leng-Peschlow, E. [Spasmolytic effect of isoasaron free calamus]. Planta Med 1985;(1):6-9. View abstract.
  • Kim, H., Moon, K. H., Ryu, S. Y., Moon, D. C., and Lee, C. K. Screening and isolation of antibiotic resistance inhibitors from herb materials IV-resistance inhibitors from Anetheum graveolens and Acorus gramineus. Arch Pharm.Res 1998;21(6):734-737. View abstract.
  • Komalamisra, N., Trongtokit, Y., Rongsriyam, Y., and Apiwathnasorn, C. Screening for larvicidal activity in some Thai plants against four mosquito vector species. Southeast Asian J Trop.Med Public Health 2005;36(6):1412-1422. View abstract.
  • Koo, B. S., Park, K. S., Ha, J. H., Park, J. H., Lim, J. C., and Lee, D. U. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm.Bull. 2003;26(7):978-982. View abstract.
  • Lai, X. Y., Liang, H., and Zhao, Y. Y. [A survey of the studies on chemical constituents and pharmacological activities of Acorus plants]. Zhongguo Zhong.Yao Za Zhi. 2002;27(3):161-5, 198. View abstract.
  • Lee, J. Y., Lee, J. Y., Yun, B. S., and Hwang, B. K. Antifungal activity of beta-asarone from rhizomes of Acorus gramineus. J Agric.Food Chem. 2-25-2004;52(4):776-780. View abstract.
  • Li, M. X. and Jiang, Z. R. [Variations of the essential oils in Acorua calamus L. and their major compositions]. Zhongguo Zhong.Yao Za Zhi. 1994;19(5):274-6, 319. View abstract.
  • Liao, W. P., Chen, L., Yi, Y. H., Sun, W. W., Gao, M. M., Su, T., and Yang, S. Q. Study of antiepileptic effect of extracts from Acorus tatarinowii Schott. Epilepsia 2005;46 Suppl 1:21-24. View abstract.
  • Lisi, D. M. Availability and uses of FDA unsafe herbs on the Internet. ASHP Midyear Clinical Meeting 1998;33:P-394D.
  • Liu, G. Q., Sun, J. N., He, Z. Z., and Jiang, Y. [Spasmolytic actions of active principles of volatile oil of Acorus gramineus]. Zhongguo Yao Li Xue.Bao. 1983;4(2):95-97. View abstract.
  • MADAN, B. R., ARORA, R. B., and KAPILA, K. Anticonvulsant, antiveratrinic and antiarrhythmic actions of Acorus calamus Linn.--an Indian indigenous drug. Arch Int Pharmacodyn.Ther. 2-1-1960;124:201-211. View abstract.
  • Maj, J., Malec, D., and Lastowski, Z. [Pharmacological properties of the native calamus (Acorus calamus L) 3. Spasmolytic effect of etheric oil]. Acta Pol.Pharm. 1966;23(5):477-482. View abstract.
  • MALHOTRA, C. L., DAS, P. K., and Dhalla, N. S. Investigations on the mechanism of potentiation of barbiturate hypnosis by hersaponin, acorus oil, reserpine and chlorpromazine. Arch Int Pharmacodyn.Ther. 8-1-1962;138:537-547. View abstract.
  • MALHOTRA, C. L., PRASAD, K., Dhalla, N. S., and DAS, P. K. Effect of hersaponin and acorus oil on noradrenaline and 5-hydroxytryptamine content of rat brain. J Pharm.Pharmacol. 1961;13:447-448. View abstract.
  • Manikandan, S. and Devi, R. S. Antioxidant property of alpha-asarone against noise-stress-induced changes in different regions of rat brain. Pharmacol Res 2005;52(6):467-474. View abstract.
  • Manikandan, S., Srikumar, R., Jeya, Parthasarathy N., and Sheela, Devi R. Protective effect of Acorus calamus LINN on free radical scavengers and lipid peroxidation in discrete regions of brain against noise stress exposed rat. Biol Pharm Bull. 2005;28(12):2327-2330. View abstract.
  • Marongiu, B., Piras, A., Porcedda, S., and Scorciapino, A. Chemical composition of the essential oil and supercritical CO2 extract of Commiphora myrrha (Nees) Engl. and of Acorus calamus L. J Agric.Food Chem 10-5-2005;53(20):7939-7943. View abstract.
  • Mathur, A. C. and Saxena, B. P. Induction of sterility in male houseflies by vapors of Acorus calamus L. oil. Naturwissenschaften 1975;62(12):576-577. View abstract.
  • Mehrotra, S., Mishra, K. P., Maurya, R., Srimal, R. C., Yadav, V. S., Pandey, R., and Singh, V. K. Anticellular and immunosuppressive properties of ethanolic extract of Acorus calamus rhizome. Int Immunopharmacol 2003;3(1):53-61. View abstract.
  • Menon, M. K. and Dandiya, P. C. The mechanism of the tranquillizing action of asarone from Acorus calamus Linn. J Pharm.Pharmacol. 1967;19(3):170-175. View abstract.
  • Narayana, D. B., Raghuvanshi, P., Agarwal, S., and Srinivas, K. S. Quantitative detection of \b/-asarone in Acorus calamus using HPTLC. Indian Drugs 1995;32:254-257.
  • Oh, M. H., Houghton, P. J., Whang, W. K., and Cho, J. H. Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity. Phytomedicine 2004;11(6):544-548. View abstract.
  • Oprean, R., Oprean, L., Tamas, M., Sandulescu, R., and Roman, L. Essential oils analysis. II. Mass spectra identification of terpene and phenylpropane derivatives. J Pharm Biomed Anal. 2001;24(5-6):1163-1168. View abstract.
  • Panchal, G. M., Venkatakrishna-Bhatt, H., Doctor, R. B., and Vajpayee, S. Pharmacology of Acorus calamus L. Indian J Exp.Biol 1989;27(6):561-567. View abstract.
  • Parab, R. S. and Mengi, S. A. Evaluation of hypolipidemic activity of Acorus calamus Linn. in rats. Indian Drugs (India) 2003;40:25-29.
  • Parab, R. S. and Mengi, S. A. Hypolipidemic activity of Acorus calamus L. in rats. Fitoterapia 2002;73(6):451-455. View abstract.
  • Patra, A. and Mitra, A. K. Constituents of Acorus calamus: structure of acoramone. Carbon-13 NMR spectra of cis- and trans-asarone. Journal of Natural Products (USA) 1981;44:668-669.
  • Pavlenko, G. E. and Shreter, A. I. [Attempt of evaluation of resources of Acorus calamus L. in the Amur Valley]. Farmatsiia. 1968;17(2):65-68. View abstract.
  • Prasad, L., Khan, T. H., Jahangir, T., and Sultana, S. Acorus calamus extracts and nickel chloride: prevention of oxidative damage and hyperproliferation response in rat kidney. Biol Trace Elem.Res 2006;113(1):77-92. View abstract.
  • Pratap, S., Kumar, P., Reddy, D., and Reddy, M. Toxicity studies of selected indian medicinal plants against house fly, Chrysomiya & Culex quinquifasciatus (MAPS-P-412). International Pharmaceutical Federation World Congress 2002;62:134.
  • Pratap, S., Reddy, D., and Reddy, M. In vitro and in vivo toxicity studies of selected Indian medicinal plants against Chrysomya bezziana (MCN-P-064). International Pharmaceutical Federation World Congress 2002;62:33.
  • Qin, X., Xu, J., Qiu, X., and Wang, W. [Effect of Acorus tatarinowii Schott. on gastrointestinal myoelectric activity in rats]. Zhongguo Zhong.Yao Za Zhi. 1998;23(2):107-9, inside. View abstract.
  • Rani, A. S., Subhadra, V. V., and Reddy, V. D. In vitro propagation of Acorus calamus Linn.--a medicinal plant. Indian J Exp.Biol 2000;38(7):730-732. View abstract.
  • Rau, O., Wurglics, M., Dingermann, T., Abdel-Tawab, M., and Schubert-Zsilavecz, M. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie 2006;61(11):952-956. View abstract.
  • Schluter, U. and Crawford, R. M. Long-term anoxia tolerance in leaves of Acorus calamus L. and Iris pseudacorus L. J Exp.Bot. 2001;52(364):2213-2225. View abstract.
  • SHARMA, J. D. and Dandiya, P. C. Studies on Acorus calamus. VI. Pharmacological actions of asarone and beta-asarone on cardiovascular system and smooth muscles. Indian J Med Res 1962;50:61-65. View abstract.
  • Shukla, P. K., Khanna, V. K., Ali, M. M., Maurya, R. R., Handa, S. S., and Srimal, R. C. Protective effect of acorus calamus against acrylamide induced neurotoxicity. Phytother.Res 2002;16(3):256-260. View abstract.
  • Shukla, P. K., Khanna, V. K., Ali, M. M., Maurya, R., Khan, M. Y., and Srimal, R. C. Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat. Hum.Exp Toxicol 2006;25(4):187-194. View abstract.
  • Sinha, A. K., Joshi, B. P., and Dogra, R. One step conversion of toxic beta-asarone from Acorus calamus into 1-(2,4,5-trimethoxyphenyl)-1,2-dihydroxypropane and asaronaldehyde occurring in Piper clusii. Nat.Prod.Lett. 2001;15(6):439-444. View abstract.
  • Sinha, A. K., Joshi, B. P., Sharma, A., Goel, H. C., and Prasad, J. Ultrasound-assisted conversion of toxic beta-asarone into nontoxic bioactive phenylpropanoid: isoacoramone, a metabolite of Piper marginatum and Acorus tararinowii. Nat.Prod.Res 2004;18(3):219-223. View abstract.
  • Sinha, A. K., Sharma, A., Joshi, B. P., and Singh, N. P. A mild conversion of phenylpropropnoid into rare phenylbutanoids: (E)-4-(2,4,5-trimethoxyphenyl)but-1,3-diene and (E)-4-(2,4,5-trimethozypheny)but-1-ene occuring in Zingiber cassumunar. Nat Prod.Res 2005;19(8):771-776. View abstract.
  • Spilkova, J., Tomasch, J., Vavra, R., and Dusek, J. Determination of \b/-asarone in the plant drug Radix calami by means of gas chromatography. Ceska A Slovenska Farmacie (Czech Republic) 1996;45:146-148.
  • Sugimoto, N., Kiuchi, F., Mikage, M., Mori, M., Mizukami, H., and Tsuda, Y. DNA profiling of Acorus calamus chemotypes differing in essential oil composition. Biol Pharm.Bull. 1999;22(5):481-485. View abstract.
  • Suryadevara, P. and Khanam, S. Screening of plant extracts for larvicidal activity against Culex quinquefasciatus. Journal of Natural Remedies 2002;2:186-188.
  • Tamas, M., Oprean, R., and Roman, L. Identification and quantitative determination of beta-asarone in essential oil and extracts of Acorus calamus L. Farmacia (Bucharest) 1996;44:13-21.
  • Vargas, C. P., Wolf, L. R., Gamm, S. R., and Koontz, K. Getting to the root (Acorus calamus) of the problem. J Toxicol Clin Toxicol 1998;36(3):259-260. View abstract.
  • Vohora, S. B., Shah, S. A., and Dandiya, P. C. Central nervous system studies on an ethanol extract of Acorus calamus rhizomes. J Ethnopharmacol. 1990;28(1):53-62. View abstract.
  • Widmer, V., Schibli, A., and Reich, E. Quantitative determination of beta-asarone in calamus by high-performance thin-layer chromatography. J AOAC Int 2005;88(5):1562-1567. View abstract.
  • Wu, L. J., Sun, L. L., Li, M., Yang, H., Jiang, Z. R., Lu, Y., Tian, Z., Zheng, Q., Miyase, T., and Ueno, A. [Studies on the constituents of the roots of Acorus calamus L.]. Yakugaku Zasshi 1994;114(3):182-185. View abstract.
  • Yabiku, H. Y., Oga, S., and Lajolo, F. M. Toxic effects of Acorus calamus oil. Preliminary study with rats and chicken embryos. Anais da Farmacia e Quimica de Sao Paulo (Brazil) 1979;19:252-258.
  • Brinker F. Herb Contraindications and Drug Interactions. Sandy, OR: Eclectic Medical Publ, 1997.
  • de Smet, P. A. A multidisciplinary overview of intoxicating snuff rituals in the western hemisphere. J Ethnopharmacol 1985;13(1):3-49. View abstract.
  • Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  • Hug G, McGraw CA, Bates SR, et al. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children. J Pediatr 1991;119:799-802. View abstract.
  • Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2000;(2):CD000145. View abstract.
  • Morrow LE, Grimsley EW. Long-term diuretic therapy in hypertensive patients: effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations. South Med J 1999;92:866-70. View abstract.
  • Sandberg AS, Brune M, Carlsson NG, et al. Inositol phosphates with different numbers of phosphate groups influence iron absorption in humans. Am J Clin Nutr 1999;70:240-6. View abstract.
  • Shoba, F. G. and Thomas, M. Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea. J Ethnopharmacol 2001;76(1):73-76. View abstract.

More Resources for CALAMUS

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2009.